Mengying Hu - Publications

Affiliations: 
2020 Eshelman School of Pharmacy University of North Carolina, Chapel Hill, Chapel Hill, NC 

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2024 Wang Y, Li S, Hu M, Yang Y, McCabe E, Zhang L, Withrow AM, Ting JP, Liu R. Universal STING mimic boosts antitumour immunity via preferential activation of tumour control signalling pathways. Nature Nanotechnology. PMID 38480836 DOI: 10.1038/s41565-024-01624-2  0.311
2023 Hu M, Kenific CM, Boudreau N, Lyden D. Tumor-derived nanoseeds condition the soil for metastatic organotropism. Seminars in Cancer Biology. PMID 37178822 DOI: 10.1016/j.semcancer.2023.05.003  0.312
2022 Li Z, Low V, Luga V, Sun J, Earlie E, Parang B, Shobana Ganesh K, Cho S, Endress J, Schild T, Hu M, Lyden D, Jin W, Guo C, Dephoure N, et al. Tumor-produced and aging-associated oncometabolite methylmalonic acid promotes cancer-associated fibroblast activation to drive metastatic progression. Nature Communications. 13: 6239. PMID 36266345 DOI: 10.1038/s41467-022-33862-0  0.322
2022 Liu X, Zhou J, Wu H, Chen S, Zhang L, Tang W, Duan L, Wang Y, McCabe E, Hu M, Yu Z, Liu H, Choi CHJ, Sung JJ, Huang L, et al. Fibrotic immune microenvironment remodelling mediates superior anti-tumor efficacy of a nano-PD-L1 trap in hepatocellular carcinoma. Molecular Therapy : the Journal of the American Society of Gene Therapy. PMID 36146933 DOI: 10.1016/j.ymthe.2022.09.012  0.538
2022 Hu M, Huang L. Strategies targeting tumor immune and stromal microenvironment and their clinical relevance. Advanced Drug Delivery Reviews. 183: 114137. PMID 35143893 DOI: 10.1016/j.addr.2022.114137  0.486
2021 Sendi H, Yazdimamaghani M, Hu M, Sultanpuram N, Wang J, Moody AS, McCabe E, Zhang J, Graboski A, Li L, Rojas JD, Dayton PA, Huang L, Wang AZ. Nanoparticle delivery of miR-122 inhibits colorectal cancer liver metastasis. Cancer Research. PMID 34753773 DOI: 10.1158/0008-5472.CAN-21-2269  0.455
2021 Qiu N, Liu Y, Liu Q, Chen Y, Shen L, Hu M, Zhou X, Shen Y, Gao J, Huang L. Corrigendum to "Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy" [Biomaterials 269 (2021) 120604]. Biomaterials. 277: 121121. PMID 34507130 DOI: 10.1016/j.biomaterials.2021.121121  0.434
2021 Wang Y, Tiruthani K, Li S, Hu M, Zhong G, Tang Y, Roy S, Zhang L, Tan J, Liao C, Liu R. mRNA Delivery of a Bispecific Single-Domain Antibody to Polarize Tumor-Associated Macrophages and Synergize Immunotherapy against Liver Malignancies. Advanced Materials (Deerfield Beach, Fla.). e2007603. PMID 33945178 DOI: 10.1002/adma.202007603  0.43
2021 Zhou X, Liu Y, Hu M, Wang M, Liu X, Huang L. Relaxin gene delivery modulates macrophages to resolve cancer fibrosis and synergizes with immune checkpoint blockade therapy. Science Advances. 7. PMID 33597232 DOI: 10.1126/sciadv.abb6596  0.658
2021 Hu M, Wang Y, Liu Z, Yu Z, Guan K, Liu M, Wang M, Tan J, Huang L. Hepatic macrophages act as a central hub for relaxin-mediated alleviation of liver fibrosis. Nature Nanotechnology. PMID 33495618 DOI: 10.1038/s41565-020-00836-6  0.592
2020 Qiu N, Liu Y, Liu Q, Chen Y, Shen L, Hu M, Zhou X, Shen Y, Gao J, Huang L. Celastrol nanoemulsion induces immunogenicity and downregulates PD-L1 to boost abscopal effect in melanoma therapy. Biomaterials. 269: 120604. PMID 33383300 DOI: 10.1016/j.biomaterials.2020.120604  0.586
2020 Yu Z, Guo J, Hu M, Gao Y, Huang L. Icaritin Exacerbates Mitophagy and Synergizes with Doxorubicin to Induce Immunogenic Cell Death in Hepatocellular Carcinoma. Acs Nano. PMID 32188241 DOI: 10.1021/Acsnano.0C00708  0.504
2020 Xu H, Hu M, Liu M, An S, Guan K, Wang M, Li L, Zhang J, Li J, Huang L. Nano-puerarin regulates tumor microenvironment and facilitates chemo- and immunotherapy in murine triple negative breast cancer model. Biomaterials. 235: 119769. PMID 31986348 DOI: 10.1016/J.Biomaterials.2020.119769  0.649
2020 Xiong Y, Song W, Shen L, Wang Y, Zhang J, Hu M, Liu Y, Li J, Musetti S, Liu R, Huang L. Oral Metformin and Polymetformin Reprogram Immunosuppressive Microenvironment and Boost Immune Checkpoint Inhibitor Therapy in Colorectal Cancer Advanced Therapeutics. 3: 2000168. DOI: 10.1002/adtp.202000168  0.619
2019 Hu M, Zhou X, Wang Y, Guan K, Huang L. Relaxin-FOLFOX-IL-12 triple combination therapy engages memory response and achieves long-term survival in colorectal cancer liver metastasis. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 31899270 DOI: 10.1016/J.Jconrel.2019.12.053  0.468
2019 Hu M, Wang Y, Xu L, An S, Tang Y, Zhou X, Li J, Liu R, Huang L. Relaxin gene delivery mitigates liver metastasis and synergizes with check point therapy. Nature Communications. 10: 2993. PMID 31278269 DOI: 10.1038/S41467-019-10893-8  0.542
2019 An S, Tiruthani K, Wang Y, Xu L, Hu M, Li J, Song W, Jiang H, Sun J, Liu R, Huang L. Locally Trapping the C-C Chemokine Receptor Type 7 by Gene Delivery Nanoparticle Inhibits Lymphatic Metastasis Prior to Tumor Resection. Small (Weinheim An Der Bergstrasse, Germany). e1805182. PMID 30690891 DOI: 10.1002/Smll.201805182  0.527
2019 Chen Y, Song W, Shen L, Qiu N, Hu M, Liu Y, Liu Q, Huang L. Vasodilator Hydralazine Promotes Nanoparticle Penetration in Advanced Desmoplastic Tumor. Acs Nano. PMID 30642161 DOI: 10.1021/acsnano.8b07830  0.462
2018 Sun H, Yang W, Tian Y, Zeng X, Zhou J, Mok MTS, Tang W, Feng Y, Xu L, Chan AWH, Tong JH, Cheung YS, Lai PBS, Wang HKS, Tsang SW, ... ... Hu M, et al. An inflammatory-CCRK circuitry drives mTORC1-dependent metabolic and immunosuppressive reprogramming in obesity-associated hepatocellular carcinoma. Nature Communications. 9: 5214. PMID 30523261 DOI: 10.1038/S41467-018-07402-8  0.38
2018 Song W, Tiruthani K, Wang Y, Shen L, Hu M, Dorosheva O, Qiu K, Kinghorn KA, Liu R, Huang L. Trapping of Lipopolysaccharide to Promote Immunotherapy against Colorectal Cancer and Attenuate Liver Metastasis. Advanced Materials (Deerfield Beach, Fla.). e1805007. PMID 30387230 DOI: 10.1002/adma.201805007  0.507
2017 Goodwin TJ, Shen L, Hu M, Li J, Feng R, Dorosheva O, Liu R, Huang L. Liver specific gene immunotherapies resolve immune suppressive ectopic lymphoid structures of liver metastases and prolong survival. Biomaterials. 141: 260-271. PMID 28700955 DOI: 10.1016/j.biomaterials.2017.07.007  0.539
2015 Zhu J, Xu X, Hu M, Qiu L. Co-Encapsulation of Combretastatin-A4 Phosphate and Doxorubicin in Polymersomes for Synergistic Therapy of Nasopharyngeal Epidermal Carcinoma. Journal of Biomedical Nanotechnology. 11: 997-1006. PMID 26353589  0.336
Show low-probability matches.